C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) A61K 38/17 (2006.01) C07K 14/705 (2006.01) C12N 15/62 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2328140
Isolated soluble RANK receptors, DNAs encoding such receptors, and pharmaceutical compositions made therefrom, are disclosed. The isolated can be used to regulate osteoclastogenesis, and hence treat disease in which there is excess bone loss.
L'invention concerne des récepteurs RANK solubles isolés, des ADN codant ces récepteurs et des compositions pharmaceutiques préparées sur cette base. Les récepteurs isolés peuvent être utilisés pour réguler l'ostéoclastogenèse et, partant, pour traiter les maladies liées à une perte excessive de masse osseuse.
Anderson Dirk M.
Galibert Laurent J.
Immunex Corporation
Smart & Biggar
LandOfFree
Method of inhibiting osteoclast activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting osteoclast activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting osteoclast activity will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1810906